ATEM Structural Discovery develops cryogenic electron microscopy (cryo-EM) for drug discovery. The startup’s platform leverages artificial intelligence (AI) to provide insights into the molecular structures of target proteins. By visualizing these structures in near-atomic detail, it identifies and optimizes drug candidates that bind with the highest affinity and specificity.